Aceso Life Science Group

Aceso Life Science Group EBIT Margin

The EBIT Margin (Operating Margin) of Aceso Life Science Group (474.HK) as of Nov 3, 2026 is -11.28 %. In the previous year, EBIT Margin (Operating Margin) was 8.33 % — a change of -235.38% (lower).

EBIT Margin

-11.28 %

YoY

-235.38%

Last updated:

EBIT Margin (Operating Margin) of Aceso Life Science Group is 2025 -11.28 % . EBIT Margin (Operating Margin) of Aceso Life Science Group was 2024 8.33 % . It decreases by -235.38% lower compared to the previous year.

Aceso Life Science Group's operating (EBIT) margin stands at -11.3%, down from 21.7% several years earlier.

The Aceso Life Science Group EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2018
-21.21 HKD
Jan 1, 2019
-5.01 HKD
Jan 1, 2020
25.46 HKD
Jan 1, 2021
21.68 HKD
Jan 1, 2022
14.29 HKD
Jan 1, 2023
25.32 HKD
Jan 1, 2024
8.33 HKD
Jan 1, 2025
-11.28 HKD
The Aceso Life Science Group EBIT Margin history
YEAREBIT MarginYoY
-11.28 %-235.38%
8.33 %-67.09%
25.32 %+77.24%
14.29 %-34.10%
21.68 %-14.86%
25.46 %-608.49%
-5.01 %-76.39%
-21.21 %-1,659.80%
1.36 %-95.78%
32.20 %-368.10%
-12.01 %-86.21%
-87.10 %+25,286.63%
-0.34 %-12.36%
-0.39 %+98.82%
-0.20 %-520.32%
0.05 %-62.01%
0.12 %-31.57%
0.18 %+17.36%
0.15 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Aceso Life Science Group Stock analysis

What does Aceso Life Science Group do? Aceso Life Science Group Ltd is a UK-based company specializing in the field of medical cannabis. The company was founded in 2016 when the founders recognized the growing demand for medical cannabis and decided to utilize their expertise in this area to establish a company focused on the development and marketing of cannabis products. Aceso's business model is based on various pillars. On one hand, the company offers product design and research and development in the field of medical cannabis products. Aceso also provides various services to help other companies and research institutions develop and bring their own commercial products to market. The company also has a strong presence in retail, where it offers a wide range of cannabinoid products. Aceso Life Science Group has various divisions that focus on the production of medical cannabis products. This includes the manufacturing of medical cannabinoids, which involves the preparation of cannabis oil and other products. Aceso also offers various types of medical cannabis, such as different THC and CBD-based products, and has also developed a special line of products targeting women. Aceso also has a strong presence in research and development, with a dedicated department focused on the development of new and improved cannabinoid products. Aceso's research department works closely with academic research institutions and other organizations to investigate and improve the efficacy and safety of medical cannabis and its derivatives. The products offered by Aceso primarily include medical oils, capsules, tinctures, and creams. These products contain a wide range of cannabinoids, such as CBD, THC, CBG, and CBN, which can be used to treat various conditions. Aceso has also developed a special series of products targeting women, including specific vaginal creams that can be used to treat pain and discomfort associated with the menstrual cycle and other conditions. Overall, Aceso Life Science Group Ltd has established itself as a leading company in the field of medical cannabis products. The company has developed a wide range of products and services aimed at providing its customers with a safe and effective way to treat various conditions. With a strong retail presence and a dedicated research department, Aceso has everything it needs to continue to play a pioneering role in the medical cannabis industry. Aceso Life Science Group is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Aceso Life Science Group stock

EBIT Margin (Operating Margin) of Aceso Life Science Group is -11.28 % in 2025.

EBIT Margin (Operating Margin) of Aceso Life Science Group changed from 8.33 % to -11.28 %, representing a -235.38% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) Aceso Life Science Group since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s Aceso Life Science Group with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Aceso Life Science Group

All Key Metrics — Aceso Life Science Group